French hospital tracks Long-Term risks for blood clot patients during COVID peak

NCT ID NCT04465656

Summary

This study aimed to understand the long-term complications for patients who had a serious blood clot in the lung (pulmonary embolism) during the first major wave of the COVID-19 pandemic in France. Researchers followed 88 patients for one year to see if their COVID-19 status (positive or negative) affected their risk of further health problems like another clot, lung damage, or death. The goal was to gather real-world data to help doctors better manage future patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital Saint Joseph Marseille

    Marseille, France

Conditions

Explore the condition pages connected to this study.